Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag Bone Marrow Safety Study in Chronic ITP
NCT01098487Phase 4Completed
- Sponsor
- GSK
- Start
- May 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 4 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by GSK. Started May 2010; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01098487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098487.